Federal Circuit upholds Humira invalidity finding

09-04-2015

Federal Circuit upholds Humira invalidity finding

Puwadol Jaturawutthichai / Shutterstock.com

The US Court of Appeals for the Federal Circuit has upheld a district court’s decision to invalidate a patent covering arthritis treatment Humira (adalimumab), after a challenge by biopharmaceutical company AbbVie.


Humira, AbbVie, Kennedy Trust, collateral estoppel, US Court of Appeals for the Federal Circuit

LSIPR